Amgen
AMGN
2,354 hedge funds and large institutions have $101B invested in Amgen in 2022 Q2 according to their latest regulatory filings, with 134 funds opening new positions, 928 increasing their positions, 924 reducing their positions, and 82 closing their positions.
82% more funds holding in top 10
Funds holding in top 10: 51 → 93 (+42)
63% more first-time investments, than exits
New positions opened: 134 | Existing positions closed: 82
1.75% more ownership
Funds ownership: 75.7% → 77.45% (+1.7%)
1% more funds holding
Funds holding: 2,337 → 2,354 (+17)
0% more repeat investments, than reductions
Existing positions increased: 928 | Existing positions reduced: 924
1% less capital invested
Capital invested by funds: $102B → $101B (-$1.31B)
18% less call options, than puts
Call options by funds: $1.66B | Put options by funds: $2.02B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$1.09B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$435M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$402M |
| 4 |
Renaissance Technologies
New York
|
+$260M |
| 5 |
Millennium Management
New York
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.06B |
| 2 |
BlackRock
New York
|
-$785M |
| 3 |
State Street
Boston,
Massachusetts
|
-$300M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$289M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$193M |
AMGN Hedge Fund Activity: Q2 2022 in Review
2,354 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2022, worth a combined $101B — down 1.3% from $102B a quarter earlier.
Buyers outnumbered sellers: 134 funds opened new AMGN positions and 82 closed out — a net gain of 52 holders — while 928 added to existing stakes and 924 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $1.09B. The largest seller was Capital Research Global Investors, cutting an estimated $1.06B.
- 2,354 institutional investors held Amgen (AMGN) as of Q2 2022, up from 2,337 in Q1 2022.
- Funds reported $101B of Amgen stock for Q2 2022, down 1.3% quarter-over-quarter.
- 134 funds opened new Amgen positions in Q2 2022 and 82 closed out, a net change of +52 holders.
- The largest Amgen buyer in Q2 2022 was Goldman Sachs, an estimated $1.09B added.
- The largest Amgen seller in Q2 2022 was Capital Research Global Investors, an estimated $1.06B sold.
Based on aggregated 13F filings for Q2 2022.